Hyperuricaemia - Where nephrology meets rheumatology

Rheumatology

Volumn 47, Issue 7, 2008, Pages 960-964

  Avram, Z ^a   Krishnan, E ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Creatinine; Kidney disease; Renal failure; Uric acid

Indexed keywords

ALLOPURINOL; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCINEURIN INHIBITOR; CONTRAST MEDIUM; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PREDNISOLONE; TACROLIMUS; URIC ACID;

CLINICAL TRIAL; COCHRANE LIBRARY; COHORT ANALYSIS; CONTRAST MEDIUM INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; EMBASE; FIBROSING ALVEOLITIS; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GOUT; GRAFT SURVIVAL; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERURICEMIA; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEDLINE; NEPHROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; URIC ACID BLOOD LEVEL;

CONTRAST MEDIA; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERURICEMIA; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; NEPHROLOGY; RHEUMATOLOGY;

EID: 45749148717     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken070     Document Type: Review

References (22)

1. Beck LH. Requiem for gouty nephropathy. Kidney Int 1986;30:280-7.
2. Talbott JH, Terplan KL. The kidney in gout. Medicine 1960;39:405-67.
3. Klinenberg JR, Gonick HC, Dornfeld L. Renal function abnormalities in patients with asymptomatic hyperuricemia. Arthritis Rheum 1975;18:725-30.
4. Patel SS, Kimmel PL, Singh A. New clinical practice guidelines for chronic kidney disease: A framework for K/DOQI. Semin Nephrol 2002;22:449-58.
5. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med 1987;82:421-6.
6. Iseki K, Oshiro S, Tozawa M, Iseki C, Ikemiya Y, Takishita S. Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. Hypertens Res 2001;24:691-7.
7. Iseki K, Ikemiya Y, Inoue T, Iseki C, Kinjo K, Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am J Kidney Dis 2004;44:642-50.
8. Tumlin JA, Madaio MP, Hennigar R. Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol 2007;2: 1054-61.
9. D'Amico G. Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-37.
10. Myllymaki J, Honkanen T, Syrjanen J et al. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Naphrol Dial Transplant 2005;20:89-95.
11. Wu J, Chen X, Xie Y et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transplant 2005;20:719-27.
12. Syrjanen J, Mustonen J, Pastemack A. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant 2000; 15:34-42.
13. Armstrong KA, Johnson DW, Campbell SB, Isbel NM, Hawley CM. Does uric acid have a pathogenetic role in graft dysfunction and hypertension in renal transplant recipients? Transplantation 2005;80:1565-71.
14. Gerhardt U, Grosse Huttmann M, Hohage H. Influence of hyperglycemia and hyperuricemia on long-term transplant survival in kidney transplant recipients. Clin transplant 1999;13:375-9.
15. Gores PF, Fryd DS, Sutherland DE, Najarian JS, Simmons RL. Hyparuricemia after renal transplantation. Am J Surg 1988;156:397-400.
16. Toprak O, Cirit M, Esi E, Postaci N, Yesil M, Bayata S. Hyperuricemia as a risk factor for contrast-induced nephropathy in patients with chronic kidney disease. Catheter Cardiovasc Interv 2006;67:227-35.
17. Siu YP, Leung KT, Tong MK, Kwan TH. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 2006;47:51-9.
18. Neal DA, Tom BD, Gimson AE, Gibbs P, Alexander GJ. Hyperuricemia, gout, and renal function after liver transplantation. Transplantation 2001;72:1689-91.
19. Kang DH, Nakagawa T, Fang L et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13:2888-97.
20. Nakagawa T, Mazzali M, Kang DH, Sanchez-Lozada LG, Herrera-Acosta J, Johnson RJ. Uric acid - a uremic toxin? Blood Purif 2006;24:67-70.
21. Khosla UM, Zharikov S, Finch JIL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-42.
22. Kang DH, Nakagawa T. Uric acid and chronic renal disease: Possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 2005;25:43-9.